Calcium Chloride Injection shortage
To Be Discontinued 1 presentations · 1 manufacturers · first FDA posting 2025-11-07 · last update 2025-11-07
Manufacturers: Hospira, Inc., a Pfizer Company
Stated reasons (per FDA): Not stated
Presentations
| Presentation | Manufacturer | Status | Reason | Notes (FDA) | Dates |
|---|---|---|---|---|---|
| Calcium Chloride, Injection, 100 mg/1 mL (NDC 0409-4928-34) | Hospira, Inc., a Pfizer Company | To Be Discontinued | — | Discontinuation of the manufacture of the drug | Posted 11/07/2025 Updated 11/07/2025 Discontinued 11/07/2025 |
Get the weekly shortage roundup: a free email of FDA shortage changes (open form)